Precision prescribing and pharmacogenomics have a key role to play in optimizing and improving patient outcomes in community care, but ensuring scalability and seamless integration are critical to its implementation.
Dr Akwasi Asabere, population genomics expert & Strategic Partnerships Director at Helix shares his insights on how we can utilize population genomics to overcome current barriers & provide actionable pharmacogenomic results as standard of care.